Home › Obesity › North Carolina › Havelock

Obesity clinical trials in Havelock, NC

17 studies for Obesity are looking for participants at sites in and around Havelock (within about 30 miles). Open a study to see who can join and how to contact the study team.

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 2

Centricity Research - Morehead city /ID# 283264, Morehead City · 15 mi away

Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07752979

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RecruitingPhase 3

Lucas Research, Inc, Morehead City · 15 mi away

Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RecruitingPhase 3

West Clinical Research, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3

West Clinical Research, Morehead City · 15 mi away

Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RecruitingPhase 2

Lucas Research, Inc, Morehead City · 15 mi away

Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RecruitingPhase 3

Carteret Medical Group, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3

AURORA-2 Clinical Site, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 3

AURORA-1 Clinical Site, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RecruitingPhase 3

Centricity Research Morehead City Multispeciality, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

RecruitingPhase 2

Lucas Research, Inc., Morehead City · 15 mi away

Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RecruitingPhase 3Healthy volunteers welcome

ACCOMPLISH-2 Research Site, Morehead City · 15 mi away

Ages 18 to 79 · All sexes · Updated Sep 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RecruitingPhase 2

Lucas Research, Inc, Morehead City · 15 mi away

Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RecruitingPhase 3

Kailera Clinical Site, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

RecruitingPhase 3

Kailera Clinical Site, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RecruitingPhase 3

West Clinical Research, Morehead City · 15 mi away

Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

RecruitingPhase 3

Kailera Clinical Site, Morehead City · 15 mi away

Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RecruitingPhase 3

Centricity Research Morehead City Specialty, Morehead City · 15 mi away

Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399

About Obesity

Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.

More about Obesity on MedlinePlus

Obesity trials in other cities

Other studies in Havelock

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.